177 related articles for article (PubMed ID: 36919725)
1. Treatment of Recurrent Antineutrophil Cytoplasmic Antibody-Associated Vasculitis After Kidney Transplant With Rituximab: A Successful Case Report.
Silva RM; Leal R; Marques MG; Rodrigues L; Santos L; Romaozinho C; Alves R; Figueiredo A
Exp Clin Transplant; 2023 Feb; 21(2):171-174. PubMed ID: 36919725
[TBL] [Abstract][Full Text] [Related]
2. Outcome of Kidney Transplant in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Buttigieg J; Henderson L; Kidder D
Exp Clin Transplant; 2017 Oct; 15(5):509-515. PubMed ID: 27765007
[TBL] [Abstract][Full Text] [Related]
3. Ectopic Relapse of Anti-neutrophil Cytoplasmic Antibody-associated Pituitary Vasculitis with No Elevation of Anti-neutrophil Cytoplasmic Antibodies after Renal Remission.
Muto R; Inagaki K; Sato N; Sameshima T; Nagakura Y; Baba S; Kato N; Maruyama S; Akahori T
Intern Med; 2020 Dec; 59(24):3187-3193. PubMed ID: 32788533
[TBL] [Abstract][Full Text] [Related]
4. Rituximab in relapsing and de novo MPO ANCA-associated vasculitis with severe renal involvement: a case series.
Caroti L; Cirami CL; Di Maria L; Larti A; Carta P; Dervishi E; Farsetti S; Tsalouchos A; Novelli L; Minetti EE
BMC Nephrol; 2019 May; 20(1):162. PubMed ID: 31088509
[TBL] [Abstract][Full Text] [Related]
5. Successful use of eculizumab in immediate ANCA vasculitis recurrence in a pediatric kidney transplant.
Peterson CG; Jackson RL
Pediatr Transplant; 2024 May; 28(3):e14760. PubMed ID: 38623882
[TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide followed by rituximab for aggressive multiple-relapsing antineutrophil cytoplasmic antibody-associated vasculitis.
Lionaki S; Fragoulis GE; Venetsanopoulou A; Vlachoyiannopoulos P; Boletis JN; Tzioufas AG
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):155-164. PubMed ID: 28134075
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Thietart S; Karras A; Augusto JF; Philipponnet C; Carron PL; Delbrel X; Mesbah R; Blaison G; Duffau P; El Karoui K; Smets P; London J; Mouthon L; Guillevin L; Terrier B; Puéchal X;
JAMA Netw Open; 2022 Jul; 5(7):e2220925. PubMed ID: 35802372
[TBL] [Abstract][Full Text] [Related]
8. Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis.
Moran S; Little MA
Curr Opin Rheumatol; 2014 Jan; 26(1):37-41. PubMed ID: 24257368
[TBL] [Abstract][Full Text] [Related]
9. ANCA Vasculitis Recurrence in Hemodialysis Patients: The Role of Rituximab.
Oliveira J; Bernardo J; Fonseca J; Marques F; Gameiro J; Outerelo C; Jorge S
Nephron; 2021; 145(6):711-716. PubMed ID: 34198295
[TBL] [Abstract][Full Text] [Related]
10. Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Single-Center 10-Year Experience.
Silva RM; Leal R; Marques MG; Rodrigues L; Santos L; Romãozinho C; Alves R; Figueiredo A
Transplant Proc; 2023; 55(6):1396-1399. PubMed ID: 37202303
[TBL] [Abstract][Full Text] [Related]
11. Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis.
McGregor JG; Hogan SL; Kotzen ES; Poulton CJ; Hu Y; Negrete-Lopez R; Kidd JM; Katsanos SL; Bunch DO; Nachman PH; Falk RJ
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1(Suppl 1):i123-31. PubMed ID: 25805743
[TBL] [Abstract][Full Text] [Related]
12. Conventional induction and maintenance treatment of Antineutrophil cytoplasmic antibodies-associated vasculitis - still of value for our patients?
Tesar V; Hruskova Z
Expert Opin Pharmacother; 2015; 16(11):1683-702. PubMed ID: 26149512
[TBL] [Abstract][Full Text] [Related]
13. Case report: de novo ANCA-associated vasculitis after kidney transplantation treated with rituximab and plasma exchange.
Sagmeister MS; Weiss M; Eichhorn P; Habicht A; Habersetzer R; Fischereder M; Schönermarck U
BMC Nephrol; 2018 Oct; 19(1):270. PubMed ID: 30340563
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study.
Jayne D; Blockmans D; Luqmani R; Moiseev S; Ji B; Green Y; Hall L; Roth D; Henderson RB; Merkel PA;
Arthritis Rheumatol; 2019 Jun; 71(6):952-963. PubMed ID: 30666823
[TBL] [Abstract][Full Text] [Related]
15. Successful induction of remission with rituximab for relapse of ANCA-associated vasculitis post-kidney transplant: report of two cases.
Geetha D; Seo P; Specks U; Fervenza FC
Am J Transplant; 2007 Dec; 7(12):2821-5. PubMed ID: 17908274
[TBL] [Abstract][Full Text] [Related]
16. Association of Serum Calprotectin (S100A8/A9) Level With Disease Relapse in Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Pepper RJ; Draibe JB; Caplin B; Fervenza FC; Hoffman GS; Kallenberg CG; Langford CA; Monach PA; Seo P; Spiera R; William St Clair E; Tchao NK; Stone JH; Specks U; Merkel PA; Salama AD;
Arthritis Rheumatol; 2017 Jan; 69(1):185-193. PubMed ID: 27428710
[TBL] [Abstract][Full Text] [Related]
17. The Pharmacogenomic Association of Fcγ Receptors and Cytochrome P450 Enzymes With Response to Rituximab or Cyclophosphamide Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Cartin-Ceba R; Indrakanti D; Specks U; Stone JH; Hoffman GS; Kallenberg CG; Langford CA; Merkel PA; Spiera RF; Monach PA; St Clair EW; Seo P; Tchao NK; Ytterberg SR; Brunetta PG; Song H; Birmingham D; Rovin BH;
Arthritis Rheumatol; 2017 Jan; 69(1):169-175. PubMed ID: 27482943
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Disease.
Casal Moura M; Irazabal MV; Eirin A; Zand L; Sethi S; Borah BJ; Winters JL; Moriarty JP; Cartin-Ceba R; Berti A; Baqir M; Thompson GE; Makol A; Warrington KJ; Thao V; Specks U; Fervenza FC
J Am Soc Nephrol; 2020 Nov; 31(11):2688-2704. PubMed ID: 32826324
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of antineutrophil cytoplasmic antibody-associated small vessel vasculitis after renal transplantation.
Marco H; Mirapeix E; Arcos E; Comas J; Ara J; Gil-Vernet S; Puig J; Vinyas O; Perello M; Oppenheimer F; Poveda R; Ibernón M; Díaz M; Ballarin J;
Clin Transplant; 2013; 27(3):338-47. PubMed ID: 23421384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
